Co-Authors
This is a "connection" page, showing publications co-authored by MATTHEW WANAT and EKERE ESSIEN.
Connection Strength
0.119
-
Impact of adherence on the cost-effectiveness of apixaban and rivaroxaban in stroke prevention among patients with atrial fibrillation in the United States. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan; 25(1):63-70.
Score: 0.060
-
Protocol for the development of a consensus practice guideline To address clinical and regulatory barriers to buprenorphine dispensing in community pharmacy. Arch Public Health. 2024 Apr 25; 82(1):58.
Score: 0.059